Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication October 21, 2016
- Published online February 1, 2017.
Article Versions
- Latest version (December 1, 2016 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2017 Free online via JRheum Full Release option
Author Information
- Graeme Jones⇑,
- Thomas Wallace,
- Matthew J. McIntosh,
- Laura Brockwell,
- Juan J. Gómez-Reino and
- Anthony Sebba
- From the Menzies Research Institute, University of Tasmania, Hobart, Australia; Genentech, South San Francisco, California; University of South Florida, Tampa, Florida, USA; Roche Products Ltd., Welwyn Garden City, UK; Hospital Clínico Universitario, Universidad de Santiago de Compostela, Santiago, Spain.
- Dr. A. Sebba has received research and consulting fees from Jansen and Jansen, Novartis, Genentech, Pfizer, Lilly, Amgen, Sandoz, and Sanofi. Dr. T. Wallace is an employee of and owns stock options in Genentech. Dr. M. McIntosh is an employee of Genentech. Dr. L. Brockwell is an employee of Roche Products Ltd.
- G. Jones, MD, PhD, Menzies Research Institute, University of Tasmania; T. Wallace, PhD, Genentech; M.J. McIntosh, PhD, Genentech; L. Brockwell, MBiochem, Roche Products Ltd.; J.J. Gómez-Reino, MD, Hospital Clínico Universitario, Universidad de Santiago de Compostela; A. Sebba, MD, University of South Florida.
- Address correspondence to Dr. G. Jones, Menzies Research Institute, University of Tasmania, 17 Liverpool St., Hobart, TAS 7001, Australia. E-mail: g.jones{at}utas.edu.au